Online, August 17, 2015 (Newswire.com) - WASHINGTON, DC - The 8th Annual marcus evans Product & Pipeline Enhancement for Generics Conference will take place October 28-29, 2015 in Washington, D.C. Single-track case study presentations, interactive panel and roundtable discussions will be delivered by generic pharmaceutical professionals at Impax Laboratories, Amneal Pharmaceuticals, Sandoz, Inc., Torrent Pharma, Dr. Reddy's Laboratories, Inc., and other leading companies. This end-user driven event will enable you to develop a robust generic product portfolio while adhering to FDA and GDUFA requirements.
Chief Scientific Officer at G&W Laboratories, Eric Mittleberg, will be giving a presentation titled "Assessing Current Generic Drug Trends to Prepare for Future R&D Market Shifts." Mr. Mittleberg will share with the delegation his first-hand experience in evaluating emerging trends in R&D to determine differences internally and externally.
The afternoon of the second conference day will feature a highly anticipated case study led by Huong Nguyen, Senior Director, Corporate & Intellectual Property Litigation at Impax Laboratories. Her session, "Assessing the Future Use of Inter Partes Review (IPRs) to Prepare for Generic Drug Submissions," will enable the delegation to address the different aspects of litigation to be able to more clearly understand litigation alternative reviews at their own respective organizations.
Additional key topics to be discussed at this generics conference include:
- Establishing a Strategic Plan to Advance Generic Business Development Initiatives
- Forging Partnerships to Enhance Portfolio Potential
- Deconstructing the Consolidation Process to Determine Impacts on the Generics Industry
Seating for this meeting is limited, and available on a first-come, first-served basis. Contact Abby Wilson today for your copy of the agenda, pricing, and registration information at AbbyW@marcusevansch.com or (312) 894-6313. Reserve your seat early to ensure availability at this exclusive event!
Source URL: http://www.marketwired.com/mw/release.do?id=2048744&sourceType=3
Share: